This study, called the AIMS Cancer Outcomes Study, is looking at how well patients with cancer do when they receive Advanced Integrative Oncology (AIO) treatment at the AIMS Institute. AIO combines standard cancer treatments with naturopathic medical care, including nutritional and botanical medicine. The study wants to understand the disease-free survival (how long patients live without their cancer returning) for those with early-stage cancer and overall survival (how long patients live) for those with advanced cancer. You might be able to join if you are a new patient with a cancer diagnosis, or an existing patient receiving treatment at the AIMS Institute. The study is currently unclear on its recruitment status.

Study design

This is an observational study, meaning researchers will collect data from 500 patients receiving care at the AIMS Institute. It is not a randomized study where treatments are assigned.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will measure survival outcomes at 5 years for some patients.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.